Session » Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases III
- 9:00AM-10:30AM
-
Abstract Number: 2574
Are Patients Classified as IPAF More Likely to Also Meet SLE Criteria by 2019 EULAR/ACR Than by SLICC?: An Abstract
- 9:00AM-10:30AM
-
Abstract Number: 2572
Autoantibody Profile of Autoimmune Driven Interstitial Lung Disease as Compared to Idiopathic Pulmonary Fibrosis and Association of Autoantibodies with Survival
- 9:00AM-10:30AM
-
Abstract Number: 2569
Efficacy and Safety of Therapeutic Interventions for the Treatment of Still’s Disease: A Systematic Review and Meta-analysis Informing the EULAR/PReS Recommendations for the Diagnosis and Management of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease
- 9:00AM-10:30AM
-
Abstract Number: 2571
Identification of Biomarkers Predicting Steroid Resistance in Immune Checkpoint Inhibitor-Induced Arthritis
- 9:00AM-10:30AM
-
Abstract Number: 2573
Prevalence of Pulmonary Hypertension in a Cohort of Patients with Interstitial Pneumonia with Autoimmune Features and Its Effect on Lung Disease Progression and Mortality
- 9:00AM-10:30AM
-
Abstract Number: 2570
Thrombosis in Patients with VEXAS Syndrome: A Retrospective Cohort Study